nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxacurium chloride—BCHE—Alzheimer's disease	0.289	1	CbGaD
Doxacurium chloride—CHRND—Galantamine—Alzheimer's disease	0.132	0.21	CbGbCtD
Doxacurium chloride—CHRNB1—Galantamine—Alzheimer's disease	0.132	0.21	CbGbCtD
Doxacurium chloride—CHRNA1—Galantamine—Alzheimer's disease	0.132	0.21	CbGbCtD
Doxacurium chloride—CHRNA2—Galantamine—Alzheimer's disease	0.0974	0.155	CbGbCtD
Doxacurium chloride—BCHE—Rivastigmine—Alzheimer's disease	0.0886	0.141	CbGbCtD
Doxacurium chloride—BCHE—Galantamine—Alzheimer's disease	0.0457	0.0727	CbGbCtD
Doxacurium chloride—Mivacurium—BCHE—Alzheimer's disease	0.00102	1	CrCbGaD
Doxacurium chloride—CHRNA2—forebrain—Alzheimer's disease	0.000598	0.126	CbGeAlD
Doxacurium chloride—CHRM2—forebrain—Alzheimer's disease	0.000356	0.0752	CbGeAlD
Doxacurium chloride—CHRM2—telencephalon—Alzheimer's disease	0.000328	0.0691	CbGeAlD
Doxacurium chloride—CHRNA2—nervous system—Alzheimer's disease	0.000324	0.0684	CbGeAlD
Doxacurium chloride—CHRNA2—central nervous system—Alzheimer's disease	0.000312	0.0659	CbGeAlD
Doxacurium chloride—CHRNA2—cerebellum—Alzheimer's disease	0.000305	0.0644	CbGeAlD
Doxacurium chloride—CHRNA1—brain—Alzheimer's disease	0.000299	0.063	CbGeAlD
Doxacurium chloride—CHRNB1—cerebellum—Alzheimer's disease	0.000284	0.0599	CbGeAlD
Doxacurium chloride—CHRNA2—brain—Alzheimer's disease	0.000248	0.0523	CbGeAlD
Doxacurium chloride—BCHE—forebrain—Alzheimer's disease	0.000237	0.05	CbGeAlD
Doxacurium chloride—CHRNB1—brain—Alzheimer's disease	0.000231	0.0487	CbGeAlD
Doxacurium chloride—BCHE—telencephalon—Alzheimer's disease	0.000218	0.046	CbGeAlD
Doxacurium chloride—CHRM2—nervous system—Alzheimer's disease	0.000194	0.0408	CbGeAlD
Doxacurium chloride—CHRM2—central nervous system—Alzheimer's disease	0.000186	0.0393	CbGeAlD
Doxacurium chloride—CHRM2—brain—Alzheimer's disease	0.000148	0.0312	CbGeAlD
Doxacurium chloride—BCHE—nervous system—Alzheimer's disease	0.000129	0.0271	CbGeAlD
Doxacurium chloride—BCHE—central nervous system—Alzheimer's disease	0.000124	0.0261	CbGeAlD
Doxacurium chloride—BCHE—cerebellum—Alzheimer's disease	0.000121	0.0255	CbGeAlD
Doxacurium chloride—BCHE—brain—Alzheimer's disease	9.83e-05	0.0207	CbGeAlD
Doxacurium chloride—CHRND—Neuronal System—PRKCG—Alzheimer's disease	7.6e-05	0.000983	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—LEP—Alzheimer's disease	7.56e-05	0.000977	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	7.36e-05	0.000951	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	7.35e-05	0.00095	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	7.3e-05	0.000943	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	7.29e-05	0.000942	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	7.28e-05	0.00094	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—TOMM40—Alzheimer's disease	7.19e-05	0.00093	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	7.19e-05	0.00093	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—GRIK2—Alzheimer's disease	7.19e-05	0.000929	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CHAT—Alzheimer's disease	7.19e-05	0.000929	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	7.1e-05	0.000917	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	7.08e-05	0.000915	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	6.94e-05	0.000896	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ADAMTS2—Alzheimer's disease	6.76e-05	0.000874	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	6.68e-05	0.000864	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—TF—Alzheimer's disease	6.61e-05	0.000854	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—CALM1—Alzheimer's disease	6.58e-05	0.00085	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	6.53e-05	0.000844	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—PRKCG—Alzheimer's disease	6.47e-05	0.000836	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—INS—Alzheimer's disease	6.46e-05	0.000835	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ATP5A1—Alzheimer's disease	6.41e-05	0.000829	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—GRIA1—Alzheimer's disease	6.41e-05	0.000828	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—GAL—Alzheimer's disease	6.35e-05	0.000821	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	6.25e-05	0.000808	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—IGF1—Alzheimer's disease	6.25e-05	0.000808	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	6.21e-05	0.000803	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	6.19e-05	0.0008	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—PRKCG—Alzheimer's disease	6.14e-05	0.000794	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	6.08e-05	0.000786	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CHRNB2—Alzheimer's disease	6.07e-05	0.000784	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	6.05e-05	0.000782	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	6.04e-05	0.000781	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—SST—Alzheimer's disease	6.04e-05	0.000781	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—CCR5—Alzheimer's disease	5.99e-05	0.000775	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	5.98e-05	0.000773	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	5.94e-05	0.000767	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—HTR2A—Alzheimer's disease	5.86e-05	0.000758	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—SLC30A6—Alzheimer's disease	5.86e-05	0.000758	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—CREB1—Alzheimer's disease	5.63e-05	0.000728	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—CALM1—Alzheimer's disease	5.59e-05	0.000723	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—ACHE—Alzheimer's disease	5.58e-05	0.000721	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—PYY—Alzheimer's disease	5.55e-05	0.000717	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CHRNA4—Alzheimer's disease	5.51e-05	0.000712	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—TPP1—Alzheimer's disease	5.45e-05	0.000705	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—CALM1—Alzheimer's disease	5.31e-05	0.000687	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	5.05e-05	0.000653	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—NPY—Alzheimer's disease	4.99e-05	0.000645	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—CREB1—Alzheimer's disease	4.79e-05	0.000619	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—DLG4—Alzheimer's disease	4.74e-05	0.000613	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	4.64e-05	0.0006	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—GRIN2B—Alzheimer's disease	4.63e-05	0.000599	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—HTR6—Alzheimer's disease	4.63e-05	0.000599	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—PLCB1—Alzheimer's disease	4.58e-05	0.000592	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—CREB1—Alzheimer's disease	4.55e-05	0.000588	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	4.51e-05	0.000583	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	4.42e-05	0.000572	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—DHCR24—Alzheimer's disease	4.36e-05	0.000564	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	4.36e-05	0.000563	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—SST—Alzheimer's disease	4.35e-05	0.000563	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	4.33e-05	0.00056	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	4.26e-05	0.000551	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—APP—Alzheimer's disease	4.24e-05	0.000548	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	4.19e-05	0.000541	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.07e-05	0.000525	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	4e-05	0.000517	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	3.97e-05	0.000513	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—GAL—Alzheimer's disease	3.85e-05	0.000497	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	3.83e-05	0.000495	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	3.81e-05	0.000492	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CA4—Alzheimer's disease	3.71e-05	0.000479	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	3.69e-05	0.000477	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	3.63e-05	0.000469	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.62e-05	0.000468	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—MME—Alzheimer's disease	3.55e-05	0.000459	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GAPDHS—Alzheimer's disease	3.49e-05	0.000451	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—F2—Alzheimer's disease	3.47e-05	0.000448	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	3.46e-05	0.000447	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—PRKCG—Alzheimer's disease	3.39e-05	0.000438	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	3.37e-05	0.000436	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ATP5A1—Alzheimer's disease	3.3e-05	0.000427	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—HSPD1—Alzheimer's disease	3.3e-05	0.000427	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	3.28e-05	0.000423	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PLD3—Alzheimer's disease	3.15e-05	0.000407	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.15e-05	0.000407	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PYY—Alzheimer's disease	3.14e-05	0.000405	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.12e-05	0.000403	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	3.04e-05	0.000393	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—HSD17B10—Alzheimer's disease	3.02e-05	0.000391	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—NPY—Alzheimer's disease	3.02e-05	0.00039	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—IAPP—Alzheimer's disease	3e-05	0.000388	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.95e-05	0.000382	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CALM1—Alzheimer's disease	2.93e-05	0.000379	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—CRH—Alzheimer's disease	2.91e-05	0.000377	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP46A1—Alzheimer's disease	2.91e-05	0.000376	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PYY—Alzheimer's disease	2.85e-05	0.000368	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ND1—Alzheimer's disease	2.81e-05	0.000363	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—CCR5—Alzheimer's disease	2.81e-05	0.000363	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	2.79e-05	0.000361	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—NPS—Alzheimer's disease	2.76e-05	0.000357	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ACHE—Alzheimer's disease	2.72e-05	0.000352	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—SST—Alzheimer's disease	2.64e-05	0.000341	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—HTR6—Alzheimer's disease	2.62e-05	0.000338	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	2.6e-05	0.000336	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—CTSD—Alzheimer's disease	2.58e-05	0.000333	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—APP—Alzheimer's disease	2.57e-05	0.000332	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	2.55e-05	0.000329	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.51e-05	0.000325	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CREB1—Alzheimer's disease	2.51e-05	0.000324	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CDK5—Alzheimer's disease	2.47e-05	0.000319	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—GSK3A—Alzheimer's disease	2.41e-05	0.000312	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—HTR6—Alzheimer's disease	2.38e-05	0.000307	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ACE—Alzheimer's disease	2.3e-05	0.000297	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	2.26e-05	0.000292	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	2.25e-05	0.000291	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	2.23e-05	0.000288	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	2.18e-05	0.000282	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GAL—Alzheimer's disease	2.17e-05	0.000281	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.16e-05	0.00028	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	1.97e-05	0.000255	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.97e-05	0.000255	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	1.92e-05	0.000249	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	1.91e-05	0.000247	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.91e-05	0.000247	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	1.84e-05	0.000237	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CHAT—Alzheimer's disease	1.81e-05	0.000234	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—TPI1—Alzheimer's disease	1.81e-05	0.000234	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—MAOB—Alzheimer's disease	1.74e-05	0.000224	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	1.71e-05	0.000221	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	1.71e-05	0.00022	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	1.7e-05	0.00022	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	1.7e-05	0.000219	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	1.68e-05	0.000217	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GAPDH—Alzheimer's disease	1.67e-05	0.000216	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	1.66e-05	0.000215	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.65e-05	0.000214	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	1.65e-05	0.000213	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.64e-05	0.000212	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.64e-05	0.000212	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—A2M—Alzheimer's disease	1.61e-05	0.000209	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	1.56e-05	0.000202	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	1.55e-05	0.0002	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	1.54e-05	0.000199	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	1.5e-05	0.000193	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	1.49e-05	0.000193	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	1.49e-05	0.000193	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	1.46e-05	0.000188	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	1.46e-05	0.000188	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	1.45e-05	0.000188	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.44e-05	0.000186	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	1.43e-05	0.000185	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	1.42e-05	0.000183	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.41e-05	0.000182	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ACHE—Alzheimer's disease	1.4e-05	0.000181	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	1.4e-05	0.000181	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—INPP5D—Alzheimer's disease	1.39e-05	0.000179	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.37e-05	0.000177	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	1.35e-05	0.000175	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	1.35e-05	0.000175	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—F2—Alzheimer's disease	1.35e-05	0.000174	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.32e-05	0.000171	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	1.32e-05	0.00017	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PTGS1—Alzheimer's disease	1.32e-05	0.00017	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ENO1—Alzheimer's disease	1.32e-05	0.00017	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	1.3e-05	0.000168	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP2D6—Alzheimer's disease	1.29e-05	0.000167	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	1.27e-05	0.000165	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	1.26e-05	0.000162	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.24e-05	0.000161	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	1.22e-05	0.000158	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—INS—Alzheimer's disease	1.22e-05	0.000158	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.2e-05	0.000155	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	1.19e-05	0.000154	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.18e-05	0.000152	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	1.17e-05	0.000151	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	1.17e-05	0.000151	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PLCB1—Alzheimer's disease	1.15e-05	0.000149	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.13e-05	0.000146	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ABCA1—Alzheimer's disease	1.12e-05	0.000145	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	1.03e-05	0.000133	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.01e-05	0.000131	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	9.95e-06	0.000129	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	9.64e-06	0.000125	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	9.6e-06	0.000124	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—HMOX1—Alzheimer's disease	9.6e-06	0.000124	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.39e-06	0.000121	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	9.2e-06	0.000119	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	9.16e-06	0.000118	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	9.1e-06	0.000118	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	8.84e-06	0.000114	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—LPL—Alzheimer's disease	8.78e-06	0.000113	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	8.72e-06	0.000113	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	8.53e-06	0.00011	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	8.38e-06	0.000108	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	8.34e-06	0.000108	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	8.24e-06	0.000106	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	8.22e-06	0.000106	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	7.99e-06	0.000103	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SST—Alzheimer's disease	7.99e-06	0.000103	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	7.99e-06	0.000103	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	7.96e-06	0.000103	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	7.92e-06	0.000102	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—MTHFR—Alzheimer's disease	7.9e-06	0.000102	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—APP—Alzheimer's disease	7.79e-06	0.000101	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	7.48e-06	9.67e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CALM1—Alzheimer's disease	7.38e-06	9.54e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—APOE—Alzheimer's disease	7.36e-06	9.51e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	7.35e-06	9.5e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CAV1—Alzheimer's disease	7.29e-06	9.42e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	6.86e-06	8.86e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	6.81e-06	8.81e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	6.7e-06	8.66e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	6.67e-06	8.62e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PPARG—Alzheimer's disease	6.41e-06	8.28e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	6.33e-06	8.18e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—INS—Alzheimer's disease	6.29e-06	8.12e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	6.03e-06	7.79e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	5.83e-06	7.53e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	5.59e-06	7.22e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	5.54e-06	7.16e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—NOS3—Alzheimer's disease	5.51e-06	7.12e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	5.43e-06	7.02e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	5.29e-06	6.84e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	5.15e-06	6.66e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PTGS2—Alzheimer's disease	5.04e-06	6.52e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	5.04e-06	6.51e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	4.7e-06	6.08e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	4.69e-06	6.05e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	4.69e-06	6.05e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	4.64e-06	6e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	4.47e-06	5.78e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—F2—Alzheimer's disease	4.42e-06	5.71e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.32e-06	5.59e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	4.06e-06	5.24e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	4.02e-06	5.2e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—INS—Alzheimer's disease	4e-06	5.17e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	3.94e-06	5.09e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	3.87e-06	5e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	3.51e-06	4.54e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.01e-06	3.89e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	2.98e-06	3.85e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	2.96e-06	3.83e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.74e-06	3.54e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.73e-06	3.53e-05	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—AKT1—Alzheimer's disease	2.53e-06	3.27e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	2.53e-06	3.27e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.32e-06	3e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.91e-06	2.47e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.75e-06	2.26e-05	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.61e-06	2.09e-05	CbGpPWpGaD
